Safety and efficacy of rituximab treatment for vasculitis in hepatitis B virus-associated type II cryoglobulinemia: a case report

INTRODUCTION: Systemic B-cell depletion and clinical remission of the systemic effects of cryoglobulins have already been achieved using rituximab in hepatitis C virus-positive immunocompetent patients. Conversely, to the best of our knowledge there are no reports in the literature regarding the use...

Full description

Saved in:
Bibliographic Details
Main Authors: Pasquet, Florian, Combarnous, François, MacGregor, Brigitte, Coppere, Brigitte, Mausservey, Christelle, Ninet, Jacques, Hot, Arnaud
Format: Artigo
Language:Inglês
Published: BioMed Central 2012
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3292813/
https://ncbi.nlm.nih.gov/pubmed/22284897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-6-39
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items